查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1631127

活性药物成分市场规模、份额、趋势分析报告：按合成类型、按製造商、按类型、按应用、按地区、按细分市场、预测，2025-2030 年

Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type of Synthesis, By Type of Manufacturer, By Type, By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 189 Pages | 商品交期: 2-10个工作天内

价格

活性药物成分市场的成长与趋势

根据Grand View Research, Inc.的新报告，到2030年全球活性药物成分市场规模预计将达到3,594.5亿美元。

预计 2025 年至 2030 年间市场复合年增长率为 5.85%。这一市场受到生物製药领域的成长、活性药物成分 (API) 製造的进步以及老年人口的成长所推动。

专属式API 领域的成长将受到那些投资应对挑战和开发内部 API 生产新化学方法的公司所推动。这有助于降低成本和污染风险。人工智慧和蛋白质合成有望提供对过程的更大控制并促进更快的发展。

心血管疾病等慢性病和生活方式驱动的疾病发生率不断上升，推动了对 API 的需求。例如，根据2020年美国药剂师学会的数据，47%的成年人至少有一个心血管疾病的危险因子。心血管疾病是全球主要的公共卫生负担之一，推动了该领域对活性药物成分的广泛研究和发展。

活性药物成分市场受到了新冠肺炎疫情的正面影响，各国和主要企业生产大量成分以满足新冠肺炎治疗的需求。由于疫情的影响，製药公司已经转变策略，将重点放在更大的患者群体。例如，为了治疗冠状病毒，美国已要求从印度进口羟氯奎。该病毒也影响了加拿大的药品供应系统，可能会为患者带来併发症。学名药重要性的日益提升、生物製药消费量的不断增加以及製药製造研发活动的不断扩大是市场成长的主要驱动力。然而，市场扩张可能会因一些国家不利的药品定价规定和高昂的製造成本而受到阻碍。

由于地缘政治因素，印度等新兴国家比中国等 API 市场主导国家更受市场青睐。此外，印度拥有高品质的原材料和产品、大量的劳动力、庞大的分销网络以及政府透过「印度製造」计划提供的补贴。

两家公司正在合作开发新治疗方法，以满足尚未满足的医疗需求。这使得公司能够利用其资源来支援产品开发并加强其供应链。 2021 年 11 月，默克宣布收购 Acceleron Pharma。此次收购预计将有助于扩大默克公司的心血管产品组合和产品线。

活性药物成分市场报告重点

  • 由于研发活动的活性化和政府积极推动开发新药，创新 API 预计将在 2024 年占据 62.0% 的最大份额。
  • 专属式API 部门在 2024 年占最大份额，为 51.03%。
  • 由于原料的可用性高且这些分子的合成方案简单，合成 API 领域在 2024 年占据了市场主导地位，收益占有率最大，为 70.66%。
  • 预计北美将在 2024 年占据最大的收益占有率，为 38.26%，并在预测期内保持领先地位。这是由于癌症以及其他文明病的流行病学不断上升，从而促进了研发活动，并进而推动了市场成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 活性药物成分市场：市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
  • 市场动态
  • 市场驱动因素
  • 市场限制因素分析
  • 商业环境分析

第 4 章 活性药物成分市场：按合成类型进行的估计和趋势分析

  • 细分仪表板
  • 活性药物成分市场：合成类型变异分析
  • 活性药物成分市场展望（按合成类型）
  • 2018-2030 年市场规模、预测及趋势分析
  • 生物API
    • 生物 API 市场，2018-2030 年
  • 组合 API
    • 合成 API 市场，2018 至 2030 年

第 5 章：按製造商类型分類的活性药物成分市场、估计和趋势分析

  • 细分仪表板
  • 活性药物成分市场：製造商类型变化分析
  • 原料药市场依製造商类型展望
  • 2018-2030 年市场规模、预测及趋势分析
  • 专属式API
    • 专属式API 市场，2018 年至 2030 年
  • 商家 API
    • 商家 API 市场，2018 至 2030 年

第六章：活性药物成分市场类型、估计与趋势分析

  • 细分仪表板
  • 活性药物成分市场：类型变化分析
  • 活性药物成分市场按类型展望
  • 2018-2030 年市场规模、预测及趋势分析
  • 通用 API
    • 非专利API 市场，2018 年至 2030 年
  • 创新 API
    • 创新 API 市场，2018-2030 年

第 7 章：活性药物成分市场：按应用分類的估计和趋势分析

  • 细分仪表板
  • 活性药物成分市场：应用趋势分析
  • 活性药物成分市场应用前景
  • 2018-2030 年市场规模、预测及趋势分析
  • 心血管疾病
    • 心血管疾病市场，2018-2030
  • 肿瘤学
    • 肿瘤学市场 2018-2030
  • 中枢神经系统和神经病学
    • 中枢神经系统和神经病学市场 2018-2030
  • 整形外科
    • 2018-2030 年整形外科市场
  • 内分泌学
    • 内分泌市场，2018-2030
  • 呼吸系统医疗设备
    • 呼吸系统医疗设备市场，2018 - 2030 年
  • 胃肠病学
    • 胃肠病学市场，2018-2030 年
  • 肾臟疾病
    • 肾臟疾病市场，2018-2030 年
  • 眼科
    • 2018-2030 年眼科市场
  • 其他的
    • 其他市场，2018-2030

第 8 章：按药物类型分類的活性药物成分市场、估计和趋势分析

  • 细分仪表板
  • 活性药物成分市场：药物类型变化分析
  • 按药物类型分類的原料药市场展望
  • 2018-2030 年市场规模、预测及趋势分析
  • 处方笺
    • 处方药市场，2018-2030 年
  • 非处方药
    • 非处方药市场，2018-2030 年

第 9 章：按地区分類的活性药物成分市场、估计和趋势分析

  • 区域控制面板
  • 2018-2030 年市场规模及预测趋势分析
  • 北美洲
    • 2018 至 2030 年北美活性药物成分市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018 至 2030 年欧洲活性药物成分市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018 年至 2030 年亚太地区活性药物成分市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018 年至 2030 年拉丁美洲活性药物成分市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018 年至 2030 年中东和非洲活性药物成分市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 参与企业概况
  • 参与企业
    • 市场领导者
    • 2024 年活性药物成分市场占有率分析
    • 公司简介
Product Code: GVR-1-68038-348-5

Active Pharmaceutical Ingredients Market Growth & Trends:

The global active pharmaceutical ingredients market size is anticipated to reach USD 359.45 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.85% from 2025 to 2030. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical Ingredients (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in-house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The active pharmaceutical Ingredients market was positively influenced by the COVID-19 pandemic, as countries and significant players produce large quantities of components to meet the demand for the treatment of COVID-19. As a result of the outbreak, drug companies have changed the companies' strategies to focus on a larger patient population. To treat coronavirus, the U.S., for example, requested that HCQ be imported from India. The virus has also impacted Canada's medicine supply system, potentially causing complications for patients. The increasing importance of generics, rise in consumption of biopharmaceuticals, and expanding drug research and development activities for drug manufacturing are the primary drivers driving the growth of the market. However, the market's expansion is likely to be hampered by unfavorable drug price control regimes in several countries and high manufacturing costs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, India has quality raw materials and products, a large workforce, a vast distribution network, and government subsidies through the "Make in India" program.

To address unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In November 2021, Merck & Co Inc. announced that it has acquired Acceleron Pharma, this acquisition would help Merck & Co to expand their cardiovascular portfolio and pipeline.

Active Pharmaceutical Ingredients Market Report Highlights:

  • Innovative APIs held the largest share of 62.0% in 2024, owing to increasing research and development activities for novel drug development and positive government initiatives
  • Captive APIs segment held the largest market share of 51.03% in 2024
  • The synthetic API segment dominated the market with the largest revenue share of 70.66% in 2024, owing to the higher availability of raw materials and easier protocols for the synthesis of these molecules
  • North America accounted for the largest revenue share of 38.26% in 2024 and is expected to maintain its lead over the forecast period. This is attributed to the rising epidemiology of cancer, along with other lifestyle-induced diseases, thus encouraging the R&D activities, thereby boosting the market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Active Pharmaceutical Ingredients Market: Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Increasing geriatric population
    • 3.4.2. Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
    • 3.4.3. Increasing preference for targeted therapy approach in cancer treatment
    • 3.4.4. Increasing preference for outsourcing APIs
  • 3.5. Market Restraint Analysis
    • 3.5.1. High capital investments and production cost
    • 3.5.2. Stringent Safety and handling regulations regarding APIs
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Active Pharmaceutical Ingredients Market: Type of Synthesis Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Active Pharmaceutical Ingredients Market: Type of Synthesis Movement Analysis
  • 4.3. Active Pharmaceutical Ingredients Market by Type of Synthesis Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Biotic APIs
    • 4.5.1. Biotic APIs Market, 2018 - 2030 (USD Billion)
      • 4.5.1.1. Biotech APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
      • 4.5.1.2. Generic APIs
        • 4.5.1.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
      • 4.5.1.3. Innovative APIs
        • 4.5.1.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)
      • 4.5.1.4. Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)
      • 4.5.1.5. Monoclonal Antibodies
        • 4.5.1.5.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Billion)
      • 4.5.1.6. Hormones
        • 4.5.1.6.1. Hormones Market, 2018 - 2030 (USD Billion)
      • 4.5.1.7. Cytokines
        • 4.5.1.7.1. Cytokines Market, 2018 - 2030 (USD Billion)
      • 4.5.1.8. Recombinant Proteins
        • 4.5.1.8.1. Recombinant Proteins Market, 2018 - 2030 (USD Billion)
      • 4.5.1.9. Therapeutic Enzymes
        • 4.5.1.9.1. Therapeutic Enzymes Market, 2018 - 2030 (USD Billion)
      • 4.5.1.10. Vaccines
        • 4.5.1.10.1. Vaccines Market, 2018 - 2030 (USD Billion)
      • 4.5.1.11. Blood Factors
        • 4.5.1.11.1. Blood Factors Market, 2018 - 2030 (USD Billion)
  • 4.6. Synthetic APIs
    • 4.6.1. Synthetic APIs Market, 2018 - 2030 (USD Billion)
      • 4.6.1.1. Synthetic APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
      • 4.6.1.2. Generic APIs
        • 4.6.1.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
      • 4.6.1.3. Innovative APIs
        • 4.6.1.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)

Chapter 5. Active Pharmaceutical Ingredients Market: Type of Manufacturer Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Active Pharmaceutical Ingredients Market: Type Movement Analysis
  • 5.3. Active Pharmaceutical Ingredients Market by Type Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Captive APIs
    • 5.5.1. Captive APIs Market, 2018 - 2030 (USD Billion)
  • 5.6. Merchant APIs
    • 5.6.1. Merchant APIs Market, 2018 - 2030 (USD Billion)

Chapter 6. Active Pharmaceutical Ingredients Market: Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Active Pharmaceutical Ingredients Market: Type Movement Analysis
  • 6.3. Active Pharmaceutical Ingredients Market by Type Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Generic APIs
    • 6.5.1. Generic APIs Market, 2018 - 2030 (USD Billion)
  • 6.6. Innovative APIs
    • 6.6.1. Innovative APIs Market, 2018 - 2030 (USD Billion)

Chapter 7. Active Pharmaceutical Ingredients Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Active Pharmaceutical Ingredients Market: Application Movement Analysis
  • 7.3. Active Pharmaceutical Ingredients Market by Application Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Cardiovascular Diseases
    • 7.5.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Billion)
  • 7.6. Oncology
    • 7.6.1. Innovative APIs Oncology Market, 2018 - 2030 (USD Billion)
  • 7.7. CNS and Neurology
    • 7.7.1. CNS and Neurology Market, 2018 - 2030 (USD Billion)
  • 7.8. Orthopedic
    • 7.8.1. Orthopedic Market, 2018 - 2030 (USD Billion)
  • 7.9. Endocrinology
    • 7.9.1. Endocrinology Market, 2018 - 2030 (USD Billion)
  • 7.10. Pulmonology
    • 7.10.1. Pulmonology Market, 2018 - 2030 (USD Billion)
  • 7.11. Gastroenterology
    • 7.11.1. Gastroenterology Market, 2018 - 2030 (USD Billion)
  • 7.12. Nephrology
    • 7.12.1. Nephrology Market, 2018 - 2030 (USD Billion)
  • 7.13. Ophthalmology
    • 7.13.1. Ophthalmology Market, 2018 - 2030 (USD Billion)
  • 7.14. Others
    • 7.14.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 8. Active Pharmaceutical Ingredients Market: Type of Drug Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Active Pharmaceutical Ingredients Market: Type of Drug Movement Analysis
  • 8.3. Active Pharmaceutical Ingredients Market by Type of Drug Outlook (USD Million)
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5. Prescription
    • 8.5.1. Prescription Market, 2018 - 2030 (USD Billion)
  • 8.6. OTC
    • 8.6.1. OTC Market, 2018 - 2030 (USD Billion)

Chapter 9. Active Pharmaceutical Ingredients Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.3. North America
    • 9.3.1. North America Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Reimbursement Scenario
      • 9.3.2.6. U.S. Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. Canada Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. Mexico Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.4. Europe
    • 9.4.1. Europe Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.2. Germany
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Reimbursement Scenario
      • 9.4.2.6. Germany Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.3. UK
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. UK Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. France Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. Italy Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. Spain Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Denmark Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Target Disease Prevalence
      • 9.4.8.3. Competitive Scenario
      • 9.4.8.4. Regulatory Framework
      • 9.4.8.5. Reimbursement Scenario
      • 9.4.8.6. Sweden Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Target Disease Prevalence
      • 9.4.9.3. Competitive Scenario
      • 9.4.9.4. Regulatory Framework
      • 9.4.9.5. Reimbursement Scenario
      • 9.4.9.6. Norway Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Reimbursement Scenario
      • 9.5.2.6. Japan Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. China Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. India Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.5. South Korea
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Prevalence
      • 9.5.5.3. Competitive Scenario
      • 9.5.5.4. Regulatory Framework
      • 9.5.5.5. Reimbursement Scenario
      • 9.5.5.6. South Korea Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.6. Australia
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Target Disease Prevalence
      • 9.5.6.3. Competitive Scenario
      • 9.5.6.4. Regulatory Framework
      • 9.5.6.5. Reimbursement Scenario
      • 9.5.6.6. Australia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.5.7. Thailand
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Target Disease Prevalence
      • 9.5.7.3. Competitive Scenario
      • 9.5.7.4. Regulatory Framework
      • 9.5.7.5. Reimbursement Scenario
      • 9.5.7.6. Thailand Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.6. Latin America
    • 9.6.1. Latin America Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Reimbursement Scenario
      • 9.6.2.6. Brazil Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. Argentina Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.7. MEA
    • 9.7.1. MEA Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Target Disease Prevalence
      • 9.7.2.3. Competitive Scenario
      • 9.7.2.4. Regulatory Framework
      • 9.7.2.5. Reimbursement Scenario
      • 9.7.2.6. South Africa Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Target Disease Prevalence
      • 9.7.3.3. Competitive Scenario
      • 9.7.3.4. Regulatory Framework
      • 9.7.3.5. Reimbursement Scenario
      • 9.7.3.6. Saudi Arabia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Target Disease Prevalence
      • 9.7.4.3. Competitive Scenario
      • 9.7.4.4. Regulatory Framework
      • 9.7.4.5. Reimbursement Scenario
      • 9.7.4.6. UAE Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Target Disease Prevalence
      • 9.7.5.3. Competitive Scenario
      • 9.7.5.4. Regulatory Framework
      • 9.7.5.5. Reimbursement Scenario
      • 9.7.5.6. Kuwait Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)

Chapter 10. Competitive Landscape

  • 10.1. Participant's overview
  • 10.2. Financial performance
  • 10.3. Participant categorization
    • 10.3.1. Market Leaders
    • 10.3.2. Active Pharmaceutical Ingredients Market Share Analysis, 2024
    • 10.3.3. Company Profiles
      • 10.3.3.1. Dr. Reddy's Laboratories Ltd.
        • 10.3.3.1.1. Company Overview
        • 10.3.3.1.2. Financial Performance
        • 10.3.3.1.3. Product Benchmarking
        • 10.3.3.1.4. Strategic Initiatives
      • 10.3.3.2. Sun Pharmaceutical Industries Ltd.
        • 10.3.3.2.1. Company Overview
        • 10.3.3.2.2. Financial Performance
        • 10.3.3.2.3. Product Benchmarking
        • 10.3.3.2.4. Strategic Initiatives
      • 10.3.3.3. Teva Pharmaceutical Industries Ltd.
        • 10.3.3.3.1. Company Overview
        • 10.3.3.3.2. Financial Performance
        • 10.3.3.3.3. Product Benchmarking
        • 10.3.3.3.4. Strategic Initiatives
      • 10.3.3.4. Cipla Inc.
        • 10.3.3.4.1. Company Overview
        • 10.3.3.4.2. Financial Performance
        • 10.3.3.4.3. Product Benchmarking
        • 10.3.3.4.4. Strategic Initiatives
      • 10.3.3.5. AbbVie Inc.
        • 10.3.3.5.1. Company Overview
        • 10.3.3.5.2. Financial Performance
        • 10.3.3.5.3. Product Benchmarking
        • 10.3.3.5.4. Strategic Initiatives
      • 10.3.3.6. Aurobindo Pharma
        • 10.3.3.6.1. Company Overview
        • 10.3.3.6.2. Financial Performance
        • 10.3.3.6.3. Product Benchmarking
        • 10.3.3.6.4. Strategic Initiatives
      • 10.3.3.7. Sandoz International GmbH (Novartis AG)
        • 10.3.3.7.1. Company Overview
        • 10.3.3.7.2. Financial Performance
        • 10.3.3.7.3. Product Benchmarking
        • 10.3.3.7.4. Strategic Initiatives
      • 10.3.3.8. Viatris Inc.
        • 10.3.3.8.1. Company Overview
        • 10.3.3.8.2. Financial Performance
        • 10.3.3.8.3. Product Benchmarking
        • 10.3.3.8.4. Strategic Initiatives
      • 10.3.3.9. Fresenius Kabi AG
        • 10.3.3.9.1. Company Overview
        • 10.3.3.9.2. Financial Performance
        • 10.3.3.9.3. Product Benchmarking
        • 10.3.3.9.4. Strategic Initiatives
      • 10.3.3.10. STADA Arzneimittel AG
        • 10.3.3.10.1. Company Overview
        • 10.3.3.10.2. Financial Performance
        • 10.3.3.10.3. Product Benchmarking
        • 10.3.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 Global Active Pharmaceutical Ingredients Market, By Region, 2018 - 2030 (USD Billion)
  • Table 2 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 3 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 4 Global Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 5 Global Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 6 Global Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 7 North America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 8 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 9 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 10 North America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 11 North America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 12 North America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 13 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 14 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 15 U.S. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 16 U.S. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 17 U.S. Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 18 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 19 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 20 Canada Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 21 Canada Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 22 Canada Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 23 Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 24 Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 25 Mexico Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 26 Mexico Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 27 Mexico Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 28 Europe Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 29 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 30 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 31 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 32 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 33 Europe Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 34 UK Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 35 UK Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 36 UK Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 37 UK Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 38 UK Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 39 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 40 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 41 Germany Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 42 Germany Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 43 Germany Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 44 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 45 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 46 France Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 47 France Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 48 France Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 49 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 50 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 51 Italy Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 52 Italy Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 53 Italy Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 54 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 55 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 56 Spain Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 57 Spain Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 58 Spain Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 59 Denmark Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 60 Denmark Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 61 Denmark Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 62 Denmark Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 63 Denmark Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 64 Sweden Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 65 Sweden Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 66 Sweden Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 67 Sweden Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 68 Sweden Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 69 Norway Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 70 Norway Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 71 Norway Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 72 Norway Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 73 Norway Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 74 Asia Pacific Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 75 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 76 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 77 Asia Pacific Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 78 Asia Pacific Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 79 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 80 Japan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 81 Japan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 82 Japan Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 83 Japan Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 84 Japan Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 85 China Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 86 China Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 87 China Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 88 China Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 89 China Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 90 India Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 91 India Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 92 India Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 93 India Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 94 India Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 95 Australia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 96 Australia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 97 Australia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 98 Australia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 99 Australia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 100 South Korea Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 101 South Korea Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 102 South Korea Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 103 South Korea Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 104 South Korea Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 105 Thailand Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 106 Thailand Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 107 Thailand Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 108 Thailand Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 109 Thailand Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 110 Latin America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 111 Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 112 Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 113 Latin America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 114 Latin America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 115 Latin America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 116 Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 117 Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 118 Brazil Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 119 Brazil Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 120 Brazil Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 121 Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 122 Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 123 Argentina Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 124 Argentina Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 125 Argentina Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 126 Middle East & Africa Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
  • Table 127 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 128 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 129 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 130 Middle East & Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 131 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 132 South Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 133 South Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 134 South Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 135 South Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 136 South Africa Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 137 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 138 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 139 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 140 Saudi Arabia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 141 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 142 UAE Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 143 UAE Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 144 UAE Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 145 UAE Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 146 UAE Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
  • Table 147 Kuwait Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
  • Table 148 Kuwait Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
  • Table 149 Kuwait Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
  • Table 150 Kuwait Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
  • Table 151 Kuwait Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 API Market market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Active pharmaceutical ingredients market: Type of synthesis movement analysis
  • Fig. 12 Biotech APIs market, 2018 - 2030 (USD Billion)
  • Fig. 13 Synthetic APIs market, 2018 - 2030 (USD Billion)
  • Fig. 14 Active pharmaceutical ingredients market: Type of manufacturer movement analysis
  • Fig. 15 Captive APIs market, 2018 - 2030 (USD Billion)
  • Fig. 16 Merchant APIs market, 2018 - 2030 (USD Billion)
  • Fig. 17 Active pharmaceutical ingredients market: Type movement analysis
  • Fig. 18 Generic APIs market, 2018 - 2030 (USD Billion)
  • Fig. 19 Innovative APIs market, 2018 - 2030 (USD Billion)
  • Fig. 20 Active pharmaceutical ingredients market: Application movement analysis
  • Fig. 21 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
  • Fig. 22 Oncology market, 2018 - 2030 (USD Billion)
  • Fig. 23 CNS and Neurology market, 2018 - 2030 (USD Billion)
  • Fig. 24 Orthopaedic market, 2018 - 2030 (USD Billion)
  • Fig. 25 Endocrinology market, 2018 - 2030 (USD Billion)
  • Fig. 26 Pulmonology market, 2018 - 2030 (USD Billion)
  • Fig. 27 Gastroenterology market, 2018 - 2030 (USD Billion)
  • Fig. 28 Nephrology market, 2018 - 2030 (USD Billion)
  • Fig. 29 Ophthalmology market, 2018 - 2030 (USD Billion)
  • Fig. 30 Others market, 2018 - 2030 (USD Billion)
  • Fig. 31 Active pharmaceutical ingredients market: Type of drug movement analysis
  • Fig. 32 Prescription market, 2018 - 2030 (USD Billion)
  • Fig. 33 OTC market, 2018 - 2030 (USD Billion)
  • Fig. 34 North America active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 35 U.S. active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 36 Canada active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 37 Mexico active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 38 Europe active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 39 UK active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 40 Germany active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 41 Italy active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 42 Spain active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 43 France active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 44 Denmark active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 45 Sweden active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 46 Norway active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 47 Asia Pacific active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 48 Japan active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 49 China active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 50 India active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 51 Australia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 52 Thailand active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 53 South Korea active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 54 Thailand active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 55 Latin America active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 56 Brazil active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 57 Argentina active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 58 MEA active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 59 South Africa active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 60 Saudi Arabia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 61 UAE active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • Fig. 62 Kuwait active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)